In addition, TNF-tg animals are develop symmetrical polyarthritis and synovial hyperplasia due to human TNF-α overexpression [32] Importantly, EFL3 could prevent inflammatory progression and joint destruction in CIA and TNF-tg animal models, further supporting its use as a therapeutic drug to treat RA. Here, EFNB1 is linked to polyarticular arthritis.